Dataset Information

Heterogeneity in statin responses explained by variation in the human gut microbiome.

ABSTRACT:

Background

Statins remain one of the most prescribed medications worldwide. While effective in decreasing atherosclerotic cardiovascular disease risk, statin use is associated with adverse effects for a subset of patients, including disrupted metabolic control and increased risk of type 2 diabetes.

Methods

We investigated the potential role of the gut microbiome in modifying patient responses to statin therapy across two independent cohorts (discovery n = 1,848, validation n = 991). Microbiome composition was assessed in these cohorts using stool 16S rRNA amplicon and shotgun metagenomic sequencing, respectively. Microbiome associations with markers of statin on-target and adverse effects were tested via a covariate-adjusted interaction analysis framework, utilizing blood metabolomics, clinical laboratory tests, genomics, and demographics data.

Findings

The hydrolyzed substrate for 3-hydroxy-3-methylglutarate-coenzyme-A (HMG-CoA) reductase, HMG, emerged as a promising marker for statin on-target effects in cross-sectional cohorts. Plasma HMG levels reflected both statin therapy intensity and known genetic markers for variable statin responses. Through exploring gut microbiome associations between blood-derived measures of statin effectiveness and adverse metabolic effects of statins, we find that heterogeneity in statin responses was consistently associated with variation in the gut microbiome across two independent cohorts. A Bacteroides-enriched and diversity-depleted gut microbiome was associated with more intense statin responses, both in terms of on-target and adverse effects.

Conclusions

With further study and refinement, gut microbiome monitoring may help inform precision statin treatment.

Funding

This research was supported by the M.J. Murdock Charitable Trust, WRF, NAM Catalyst Award, and NIH grant U19AG023122 awarded by the NIA.

SUBMITTER: Wilmanski T

PROVIDER: S-EPMC9261472 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Heterogeneity in statin responses explained by variation in the human gut microbiome.

Wilmanski Tomasz T Kornilov Sergey A SA Diener Christian C Conomos Matthew P MP Lovejoy Jennifer C JC Sebastiani Paola P Orwoll Eric S ES Hood Leroy L Price Nathan D ND Rappaport Noa N Magis Andrew T AT Gibbons Sean M SM

Med (New York, N.Y.) 20220511 6

<h4>Background</h4>Statins remain one of the most prescribed medications worldwide. While effective in decreasing atherosclerotic cardiovascular disease risk, statin use is associated with adverse effects for a subset of patients, including disrupted metabolic control and increased risk of type 2 diabetes.<h4>Methods</h4>We investigated the potential role of the gut microbiome in modifying patient responses to statin therapy across two independent cohorts (discovery n = 1,848, validation n = 991 ...[more]

PMID: 35690059

Similar Datasets

Project description:The central aim of this meta-analysis was to determine whether the rumen microbiome can serve as an accurate predictor of performance in beef and dairy cattle compared with predictions based on diet composition. To support this comparison, a set of models was derived and compared. Models predicted milk yield (MY), average daily gain (ADG), dry matter intake (DMI), dairy feed efficiency (FE), and beef FE using different sets of independent variables: diet (D), microbial (M), and experimental (E). Diet variables included dry matter, organic matter, neutral detergent fiber, acid detergent fiber, crude protein, ether extract, nonfiber carbohydrate, starch, and forage percentages. Microbiome variables included relative abundance of 3 major rumen bacterial phyla, species richness, and species diversity. Experimental variables included publication year, breed type (dairy, beef, or Bos indicus), and rumen sampling fraction (fluid or solid). A second set of models used D and E variables as predictors for the microbiome. For both the production and microbiome model sets, predictor variable sets were used individually and in combination. Linear mixed-effects regression, weighted by 1/standard error of the mean, was used to derive models using data from 51 peer-reviewed publications. Models for the same response variable were compared on the basis of concordance correlation coefficient with study effects removed (uCCC), root-estimated variance associated with study and error, and corrected Akaike information criterion values, wherever appropriate. The MY model using D + M + E predictors outperformed all other MY models (uCCC = 0.71). ADG was most accurately predicted by D alone (uCCC = 0.92). Interestingly, M + E was more successful at predicting DMI than any model using D variables. Similarly, dairy FE was more accurately predicted by M + E than D, albeit only slightly (uCCC = 0.69 vs. 0.65). Beef FE could only be modeled using D variables. Overall, breed type proved a better predictor of relative abundances of most rumen bacterial phyla than D. Conversely, species richness and diversity indicators were unaffected by breed type, but could be predicted by D with moderate precision and accuracy (uCCC = 0.63 to 0.69). This analysis suggests that diet and the microbiome may exert independent effects on various aspects of performance. Further research is necessary to determine the reasons for these independent influences.

Project description:Recent population-based1-4 and clinical studies5 have identified a range of factors associated with human gut microbiome variation. Murine quantitative trait loci6, human twin studies7 and microbiome genome-wide association studies1,3,8-12 have provided evidence for genetic contributions to microbiome composition. Despite this, there is still poor overlap in genetic association across human studies. Using appropriate taxon-specific models, along with support from independent cohorts, we show an association between human host genotype and gut microbiome variation. We also suggest that interpretation of applied analyses using genetic associations is complicated by the probable overlap between genetic contributions and heritable components of host environment. Using faecal 16S ribosomal RNA gene sequences and host genotype data from the Flemish Gut Flora Project (n = 2,223) and two German cohorts (FoCus, n = 950; PopGen, n = 717), we identify genetic associations involving multiple microbial traits. Two of these associations achieved a study-level threshold of P = 1.57 × 10-10; an association between Ruminococcus and rs150018970 near RAPGEF1 on chromosome 9, and between Coprococcus and rs561177583 within LINC01787 on chromosome 1. Exploratory analyses were undertaken using 11 other genome-wide associations with strong evidence for association (P < 2.5 × 10-8) and a previously reported signal of association between rs4988235 (MCM6/LCT) and Bifidobacterium. Across these 14 single-nucleotide polymorphisms there was evidence of signal overlap with other genome-wide association studies, including those for age at menarche and cardiometabolic traits. Mendelian randomization analysis was able to estimate associations between microbial traits and disease (including Bifidobacterium and body composition); however, in the absence of clear microbiome-driven effects, caution is needed in interpretation. Overall, this work marks a growing catalogue of genetic associations that will provide insight into the contribution of host genotype to gut microbiome. Despite this, the uncertain origin of association signals will likely complicate future work looking to dissect function or use associations for causal inference analysis.

Dataset Information

Heterogeneity in statin responses explained by variation in the human gut microbiome.

Background

Methods

Findings

Conclusions

Funding

Publications

Heterogeneity in statin responses explained by variation in the human gut microbiome.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets